Affiliation: | 1. Chemical Development, Boehringer‐Ingelheim Pharmaceuticals Inc. 900 Ridgebury Road, P.O. Box 368, Ridgefield, CT 06877‐0368 (USA);2. Research and Development, Boehringer Ingelheim (Canada) Ltd. 2100 Cunard Street, Laval, Québec H7S 2G5 (Canada) |